Management of symptoms is an important aspect of care delivery for patients undergoing chemotherapy treatment. Symptoms associated with chemotherapy can be wide ranging, complex, and, if incorrectly managed, life-threatening. The Advanced Symptom Management System (ASyMS) − III study is investigating the impact of ASyMS on the care delivered to people with breast and colorectal cancer receiving adjuvant chemotherapy. Part of this research involves understanding the different models of care employed by different hospitals across the UK in order to evaluate the impact ASyMS has on current care delivery. In this presentation we describe the use of process of care mapping to elicit symptom management care pathways in 8 cancer settings across the UK.
|Number of pages||1|
|Publication status||Published - 2013|
|Event||ECCO 17: The European Cancer Congress 2013 - |
Duration: 27 Sep 2013 → 1 Oct 2013
|Conference||ECCO 17: The European Cancer Congress 2013|
|Period||27/09/13 → 1/10/13|